CLUSTER filed Sep 9, 2026 at 14:37 ET
Two UroGen Pharma insiders, the Chief Medical Officer and General Counsel, sold a combined $102K in open-market shares on September 8, 2026, following non-cash option exercises the prior day. At a $2.1B market cap, the sales represent ~0.005% of market cap, well below the 0.1% threshold for materiality, and the exercise-and-sell pattern is consistent with routine tax-planning or diversification, not a bearish signal. The cluster is neutral, the dollar amount is trivial relative to company size, and the sales are liquidity-driven.